Invention Grant
- Patent Title: Cathelicidin as novel inflammatory bowel disease marker and therapy for colitis associated intestinal fibrosis
-
Application No.: US14648207Application Date: 2013-12-10
-
Publication No.: US09651562B2Publication Date: 2017-05-16
- Inventor: Hon Wai Koon , Charalabos Pothoulakis
- Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
- Applicant Address: US CA Oakland
- Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
- Current Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
- Current Assignee Address: US CA Oakland
- Agency: canady + lortz LLP
- Agent Karen S Canady
- International Application: PCT/US2013/074034 WO 20131210
- International Announcement: WO2014/093297 WO 20140619
- Main IPC: A61K38/00
- IPC: A61K38/00 ; G01N33/68 ; A61K31/19 ; A61K35/74 ; A61K35/741 ; A61K38/17 ; A61K39/395 ; A61K45/06 ; A61K35/00 ; A61K39/00
Abstract:
Method of diagnosing and treating inflammatory bowel disease are disclosed herein. Inflammatory bowel disease can be treated and diagnosed using cathelicidin peptides and detection agents thereof. Specifically, method of treating and diagnosing Crohn's disease and ulcerative colitis are disclosed herein.
Public/Granted literature
Information query
IPC分类:
